Sandbox/a: Difference between revisions

Jump to navigation Jump to search
Line 6: Line 6:
==History and Symptoms==
==History and Symptoms==


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
{| style="float: right; border: 0px; font-size: 90%; margin: 3px;"
! style="width: 300px;background: #4479BA"|{{fontcolor|#FFF| '''''Community-onset infection '''''}}
! style="width: 300px;background: #4479BA"|{{fontcolor|#FFF| '''''Community-onset infection '''''}}
! style="width: 300px;background: #4479BA"|{{fontcolor|#FFF| '''''Hospital-onset infection '''''}}
! style="width: 300px;background: #4479BA"|{{fontcolor|#FFF| '''''Hospital-onset infection '''''}}
|-
|-
|  style="width: 120px;background: #F5F5F5"| Includes patients with 1 or more of the following conditions:
|  style="width: 120px;background: #F5F5F5"| Fever
*The presence of an invasive device at time of admission
|  style="width: 120px;background: #F5F5F5"| 98%
*History of [[MRSA]] infection or colonization
*History of surgery, hospitalization, [[dialysis]], or residence in a long-term care facility in the previous 12 months.
|  style="width: 120px;background: #F5F5F5"| Includes patients with positive culture results obtained >48 h after admission. <br> Patients might also have 1 of the conditions described in community-onset infection.
|-
|-
|  style="width: 120px;background: #F5F5F5"| Fever with chills or rigors
|  style="width: 120px;background: #F5F5F5"| 87%
|-
|  style="width: 120px;background: #F5F5F5"|
|  style="width: 120px;background: #F5F5F5"|
|-
|  style="width: 120px;background: #F5F5F5"|
|  style="width: 120px;background: #F5F5F5"|
|-
|  style="width: 120px;background: #F5F5F5"|
|  style="width: 120px;background: #F5F5F5"|
|-
|  style="width: 120px;background: #F5F5F5"|
|  style="width: 120px;background: #F5F5F5"|
|-
|  style="width: 120px;background: #F5F5F5"|
|  style="width: 120px;background: #F5F5F5"|
|-
|}
|}



Revision as of 15:48, 17 June 2014

Middle East Respiratory Syndrome Coronavirus Infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Middle East Respiratory Syndrome Coronavirus Infection from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Contact and Airborne Precautions

Primary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Sandbox/a On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox/a

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox/a

CDC on Sandbox/a

Sandbox/a in the news

Blogs on Sandbox/a

Directions to Hospitals Treating Middle East respiratory syndrome coronavirus infection

Risk calculators and risk factors for Sandbox/a

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The symptoms of the middle east respiratory syndrome coronavirus infection include fever, cough, shortness of breath and gatsrointestinal symptoms.

History and Symptoms

Community-onset infection Hospital-onset infection
Fever 98%
Fever with chills or rigors 87%

Suspect MERS-CoV infection in case of:

  • Fever (≥38°C, 100.4°F) and pneumonia or acute respiratory distress syndrome (based on clinical or radiological evidence);

AND EITHER

  • History of travel from countries in or near the Arabian Peninsula1 within 14 days before symptom onset;

OR

  • Close contact2 with a symptomatic traveler who developed fever and acute respiratory illness (not necessarily pneumonia) within 14 days after traveling from countries in or near the Arabian Peninsula;

OR

  • Is a member of a cluster of patients with severe acute respiratory illness (e.g. fever and pneumonia requiring hospitalization) of unknown etiology in which MERS-CoV is being evaluated, in consultation with state and local health departments.

Symptoms

All but two patients (96%) had one or more chronic medical conditions, including diabetes (68%), hypertension (34%), heart disease (28%), and kidney disease (49%). Thirty-four (72%) had more than one chronic condition.

References

Template:WH Template:WS